NM_024079.5:c.139A>T
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM5PP3_Moderate
The NM_024079.5(ALG8):c.139A>T(p.Thr47Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T47P) has been classified as Pathogenic.
Frequency
Consequence
NM_024079.5 missense
Scores
Clinical Significance
Conservation
Publications
- ALG8-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- polycystic liver disease 3 with or without kidney cystsInheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024079.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALG8 | NM_024079.5 | MANE Select | c.139A>T | p.Thr47Ser | missense | Exon 2 of 13 | NP_076984.2 | ||
| ALG8 | NM_001425224.1 | c.139A>T | p.Thr47Ser | missense | Exon 2 of 14 | NP_001412153.1 | |||
| ALG8 | NM_001425225.1 | c.139A>T | p.Thr47Ser | missense | Exon 2 of 14 | NP_001412154.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALG8 | ENST00000299626.10 | TSL:1 MANE Select | c.139A>T | p.Thr47Ser | missense | Exon 2 of 13 | ENSP00000299626.5 | ||
| ALG8 | ENST00000532050.5 | TSL:1 | n.139A>T | non_coding_transcript_exon | Exon 2 of 8 | ENSP00000437199.1 | |||
| ALG8 | ENST00000679559.1 | c.139A>T | p.Thr47Ser | missense | Exon 2 of 14 | ENSP00000505433.1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151726Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251380 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461776Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727188 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151824Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74176 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
ALG8 congenital disorder of glycosylation;C4693472:Polycystic liver disease 3 with or without kidney cysts Uncertain:1
Inborn genetic diseases Uncertain:1
The c.139A>T (p.T47S) alteration is located in exon 2 (coding exon 2) of the ALG8 gene. This alteration results from a A to T substitution at nucleotide position 139, causing the threonine (T) at amino acid position 47 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at